Clinical trial: extended treatment duration of peginterferon-alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1-infected late responders-Reference-Cited by-同舟云学术

Clinical trial: extended treatment duration of peginterferon-alpha2b plus ribavirin for 72 and 96 weeks in hepatitis C genotype 1-infected late responders

Published:2009-08 Issue:4 Volume:30 Page:343-351
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

NAGAKI M.,SHIMIZU M.,SUGIHARA J. I.,TOMITA E.,SANO C.,NAIKI T.,KIMURA K.,AMANO K.,SAKAI T.,NINOMIYA M.,KOJIMA T.,KATSUMURA N.,FUJIMOTO M.,MORIWAKI H.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2009.04048.x/fullpdf

Reference21 articles.

1. National Institutes of Health consensus development conference: management of hepatitis C: 2002;Seeff;Hepatology,2002

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

4. Peginterferon-alfa-2a plus ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

5. Prospective study on early virologic response to treatment with interferon alpha-2b plus rebavirin in patients with chronic hepatitis C genotype 1b;Nagaki;Hepatol Res,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of boceprevir: a first-in-class direct antiviral treatment for chronic hepatitis C infection;Annals of the New York Academy of Sciences;2013-07

2. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients;Cochrane Database of Systematic Reviews;2012-09-12

3. Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis;Hepatitis Monthly;2011-08-30

4. Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis;Hepatitis Monthly;2011-08-01

5. Impact of ribavirin dose reduction on the efficacy of pegylated interferon plus ribavirin combination therapy for elderly patients infected with genotype 1b and high viral loads;Hepatology Research;2011-06-28